medicationPrescription only (US)Atenolol is an FDA-approved beta-blocker for hypertension and anginaThe cited 2004 Lancet review and the LIFE trial both raised questions about atenolol's comparative benefit versus other antihypertensives on stroke and cardiovascular endpoints, which has shifted many prescribing guidelines away from atenolol as a first-line agent
AtenololBenefits, Dosage & Interactions
Also known as: Tenormin
Atenolol is a beta-adrenergic blocking agent, commonly referred to as a beta-blocker. It is primarily used to treat various cardiovascular conditions. It is typically taken in the morning. The reported plasma half-life is about 6 hours, which shapes dosing frequency.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Strong — 1 human randomized trial and regulatory approval on file.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence
1 human randomized trial and regulatory approval on file.
Plasma half-life
6–7 h
Typical timing
morning
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- 50–100 mg once daily was the atenolol-based comparator regimen in the LIFE hypertension trial, consistent with the dose range reviewed in the Lancet critique of atenolol[1][2]
Reported for Atenolol in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Atenolol entry is written from. Each number matches an inline marker above.
- [1]Atenolol in hypertension: is it a wise choice?Carlberg B, Samuelsson O, Lindholm LH · Lancet · 2004 · Peer-reviewed · PMID 15530629
- [2]Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololDahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U · Lancet · 2002 · Peer-reviewed · PMID 11937178
How to track Atenolol doses
Tracking Atenolol well takes four fields and a habit. Here is what to record so the log is still useful in three months.
- 1
Add the dose and unit
Log Atenolol with its dose in mg so totals stay comparable over time — including days when you split the dose or skip it.
- 2
Set the time of day and food rule
Typical timing is morning. Reminders fire at that time and can export to your calendar.
- 3
Check it against the rest of the stack
Run Atenolol through the interaction checker against everything else in the routine — supplements, peptides, hormones and prescriptions — before it becomes a daily habit.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
With a reported half-life around 6 h, effects and timing shifts show up over days rather than instantly. Review Atenolol alongside your logged metrics and any relevant blood work every few weeks before changing the dose.
What to log each time
- Dose in mg
- Time of day
- Taken / skipped / delayed
- Any side effects or notable changes
References & Evidence
Sources on this page that document Atenolol dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Atenolol?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Atenolol is a beta-adrenergic blocking agent, commonly referred to as a beta-blocker. It is primarily used to treat various cardiovascular conditions. Its mechanism of action involves selectively blocking beta-1 adrenoceptors, predominantly found in the heart, leading to a reduction in heart rate and myocardial contractility. This action helps to decrease the heart's workload and oxygen demand. Atenolol is available in oral tablet form.
First synthesized in the 1970s, atenolol became a widely used medication due to its relative cardioselectivity compared to earlier non-selective beta-blockers. While initially thought to offer significant advantages in patients with respiratory conditions like asthma, later research has shown that cardioselectivity is dose-dependent and can be lost at higher doses. It is metabolized to a limited extent by the liver and primarily excreted unchanged by the kidneys, which is an important consideration in patients with renal impairment. Its half-life averages around 7 hours, allowing for once-daily dosing for many indications. (DrugBank, MedlinePlus)
What does the research say about Atenolol?
Tap a section to expand.
Atenolol selectively blocks beta-1 adrenergic receptors, which are primarily located in the cardiac muscle. By binding to these receptors, atenolol prevents the action of catecholamines (like adrenaline and noradrenaline) on the heart. This blockade leads to several physiological effects:
* **Decreased Heart Rate (Negative Chronotropy):** Reduces the speed at which the heart beats.
* **Decreased Myocardial Contractility (Negative Inotropy):** Lessens the force with which the heart muscle contracts.
* **Reduced Cardiac Output:** The overall volume of blood pumped by the heart per minute decreases.
* **Decreased Renin Release:** Atenolol can inhibit the release of renin from the kidneys, an enzyme involved in the renin-angiotensin-aldosterone system, contributing to blood pressure regulation.
These combined actions result in a reduction in myocardial oxygen demand, which is beneficial in conditions like angina, and a lowering of blood pressure in hypertensive patients. The cardioselective nature of atenolol means it has less effect on beta-2 receptors, which are found in bronchial and vascular smooth muscle, though this selectivity is not absolute, especially at higher doses. (DrugBank, FDA label)
Source for this section: Sources for How does Atenolol work?: Jumps to this entry in the sources and references list at the end of the page.
Atenolol is indicated for the management of several cardiovascular conditions (FDA label, MedlinePlus):
* **Hypertension (High Blood Pressure):** It is used alone or in combination with other antihypertensive agents to lower blood pressure, thereby reducing the risk of cardiovascular events such as stroke and heart attack.
* **Angina Pectoris (Chest Pain):** Atenolol helps reduce the frequency and severity of angina attacks by decreasing the heart's workload and oxygen demand during exercise and stress. Its anti-anginal effect is thought to be related to the reduction in heart rate and myocardial contractility.
* **Myocardial Infarction (Heart Attack):** In the acute phase of a heart attack and for long-term secondary prevention, atenolol can be used to improve survival by reducing the risk of reinfarction and ventricular fibrillation. It helps to limit infarct size and reduce the likelihood of sudden cardiac death.
Some off-label uses, where evidence may be less robust or indications are not FDA-approved, may include certain types of arrhythmias or anxiety-related symptoms, but these would be at the discretion of a clinician. (Mayo Clinic)
The efficacy of atenolol in treating hypertension, angina pectoris, and for secondary prevention post-myocardial infarction is well-established through numerous clinical trials and systematic reviews. (Cochrane Library, FDA label)
For hypertension, atenolol has been shown to be effective in lowering both systolic and diastolic blood pressure. Studies comparing beta-blockers, including atenolol, to other classes of antihypertensives have demonstrated their utility, particularly in younger patients or those with comorbid conditions like angina. (Journal of Hypertension)
In angina pectoris, evidence consistently shows that atenolol reduces the frequency and severity of anginal episodes and improves exercise tolerance. Its role in the management of stable angina is a cornerstone of therapy, as outlined by professional cardiology guidelines. (American College of Cardiology / American Heart Association guidelines)
Following a myocardial infarction, atenolol and other beta-blockers have been extensively studied and are recommended for their cardioprotective effects. Meta-analyses have confirmed their ability to reduce mortality and morbidity in this patient population. (The Lancet, Circulation)
Like all medications, atenolol can cause side effects. Many are mild and transient, but others can be more serious (FDA label, MedlinePlus):
* **Common Side Effects:** Fatigue, bradycardia (slow heart rate), dizziness, lightheadedness, cold extremities, nausea, diarrhea, depression, and shortness of breath.
* **Less Common/More Serious Side Effects:** Bronchospasm (especially in susceptible individuals), worsening of heart failure, masking of hypoglycemia symptoms in diabetic patients, sexual dysfunction, and rash. Rarely, severe allergic reactions.
If any side effects persist or worsen, medical attention should be sought. Do not discontinue atenolol abruptly without consulting a clinician, as this can lead to rebound hypertension or exacerbation of angina.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Several warnings and precautions are associated with atenolol use (FDA label, MedlinePlus):
* **Abrupt Cessation:** Do not discontinue atenolol abruptly, especially in patients with ischemic heart disease. Tapering the dose gradually over 1 to 2 weeks is generally recommended to avoid exacerbations of angina, myocardial infarction, and arrhythmias due to beta-receptor upregulation.
* **Patients with Bronchospastic Disease:** While atenolol is cardioselective, its selectivity is not absolute. In patients with asthma, chronic obstructive pulmonary disease (COPD), or other bronchospastic conditions, beta-blockers can cause bronchospasm. If a beta-blocker is required, the lowest possible dose of a cardioselective agent should be used with caution, and a bronchodilator should be readily available.
* **Diabetes and Hypoglycemia:** Atenolol can mask symptoms of hypoglycemia (e.g., tremor, palpitation, tachycardia) in diabetic patients, making it harder for them to recognize and manage low blood sugar. It can also prolong insulin-induced hypoglycemia.
* **Peripheral Vascular Disease:** Beta-blockers may precipitate or aggravate symptoms of arterial insufficiency in patients with peripheral vascular disease.
* **Thyrotoxicosis:** Atenolol can mask the clinical signs of hyperthyroidism, such as tachycardia. Abrupt withdrawal may precipitate a thyroid storm.
* **Renal Impairment:** Since atenolol is primarily excreted by the kidneys, dose adjustment is necessary in patients with significant renal impairment to prevent accumulation and adverse effects.
* **Anesthesia and Major Surgery:** Beta-blockade impairs the heart's ability to respond to reflex adrenergic stimuli. The necessity or desirability of withdrawing beta-blocking therapy prior to major surgery is controversial, but caution should be exercised.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Atenolol is contraindicated in certain medical conditions due to the risk of severe adverse effects (FDA label, MedlinePlus):
* **Sinus Bradycardia:** A heart rate that is too slow.
* **Greater than First-Degree Heart Block:** Severe disturbances in the electrical conduction system of the heart.
* **Cardiogenic Shock:** A severe form of heart failure where the heart cannot pump enough blood to meet the body's needs.
* **Overt Cardiac Failure:** Decompensated heart failure that is not adequately controlled.
* **Hypersensitivity:** Known allergy to atenolol or any components of the formulation.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Combining atenolol with certain other medications can lead to adverse interactions and should be carefully managed or avoided (FDA label, DrugBank):
* **Calcium Channel Blockers (e.g., verapamil, diltiazem):** Co-administration can lead to additive effects on atrioventricular conduction and myocardial contractility, potentially resulting in severe bradycardia, heart block, and heart failure.
* **Clonidine:** If clonidine is discontinued, and atenolol is also being taken, the atenolol should be withdrawn several days before the gradual discontinuation of clonidine to avoid a hypertensive crisis.
* **Digitalis Glycosides (e.g., digoxin):** Both atenolol and digitalis slow atrioventricular conduction and heart rate. Concomitant use can lead to excessive bradycardia and heart block.
* **Sympathomimetic Agents (e.g., epinephrine, norepinephrine, decongestants):** These drugs can counteract the effects of atenolol and may lead to hypertension and bradycardia due to unopposed alpha-adrenergic stimulation.
* **Nonsteroidal Anti-inflammatory Drugs (NSAIDs):** NSAIDs, particularly chronic use, may diminish the antihypertensive effect of beta-blockers.
* **Insulin and Oral Hypoglycemic Agents:** Atenolol can intensify the blood sugar-lowering effect of these drugs and mask symptoms of hypoglycemia.
* **Class I Antiarrhythmic Agents (e.g., disopyramide):** Can have additive negative inotropic and dromotropic effects, increasing the risk of adverse cardiac events.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Atenolol is typically administered once daily, often in the morning, due to its half-life of approximately 7 hours which allows for a sustained therapeutic effect over 24 hours. It can be taken with or without food. The dose is user-directed and must be set by a licensed clinician. (FDA label, MedlinePlus)
Source for this section: Sources for When should you take Atenolol?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Atenolol?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pending | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
| Any vitamin + medication | Note | Category ruleConfidence: theoretical | Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).Source pending | Specific pairs are checked against a licensed source; confirm with your provider. |
Frequently asked questions about Atenolol
Atenolol is primarily used to treat high blood pressure (hypertension), chest pain (angina pectoris), and to improve outcomes after a heart attack (myocardial infarction).
Atenolol works by selectively blocking beta-1 receptors in the heart, reducing heart rate and the force of heart muscle contraction, thereby lowering the heart's workload and oxygen demand.
No, it is very important not to stop taking atenolol abruptly without consulting your doctor. Suddenly stopping the medication can lead to serious heart problems, including rebound high blood pressure, worsening angina, or even a heart attack.
There are no specific foods or drinks that are strictly prohibited with atenolol. However, consuming alcohol while taking atenolol may enhance the blood pressure lowering effect and cause increased dizziness. As with all medications, discuss your diet with your prescribing clinician.
If you miss a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.
As a medication, Atenolol can overlap with other supplements, prescription medicines, hormones and peptides. Because Atenolol is usually taken in the morning, most avoidable conflicts come from what else lands in that same window. With a reported plasma half-life near 6 hours, separating doses can change the picture as much as removing one. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Atenolol with no sign-up.
Whether Atenolol fits alongside testosterone replacement therapy depends on the protocol — dose, ester and ancillaries such as HCG or anastrozole — and on current bloodwork. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
"Peptides" is not one category — healing peptides, GLP-1 agonists, growth-hormone secretagogues and melanocortins each behave differently next to Atenolol. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
A short plasma half-life of roughly 6 hours is why protocols often split Atenolol across the day rather than using a single dose. It is typically taken in the morning. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
For Atenolol the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at Atenolol?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Clinical pharmacokinetics of atenolol--a review(opens PubMed in a new tab)Eur J Drug Metab Pharmacokinet · 1982 · PMID 6749509 · https://pubmed.ncbi.nlm.nih.gov/6749509/
- 2.Systematic Review on the Efficacy of Atenolol in Antihypertensive Treatment: Recommendation from the Brazilian Society of Cardiology(opens PubMed in a new tab)Arq Bras Cardiol · 2025 · PMID 41036884 · https://pubmed.ncbi.nlm.nih.gov/41036884/
- 3.Bioavailability of atenolol formulations(opens PubMed in a new tab)Biopharm Drug Dispos · 1980 · PMID 7459427 · https://pubmed.ncbi.nlm.nih.gov/7459427/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 2249(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/2249
Verify at
Publisher search links for Atenolol. These are places to check the information — they are not citations, so they are not numbered.
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- FDA-approved labeling (DailyMed)(publisher search, opens in a new tab)U.S. Food and Drug Administration · publisher search
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- Clinical practice guidelines (PubMed)(publisher search, opens in a new tab)National Library of Medicine · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Atenolol?
Plain-text summary, safe to quote verbatim:
Atenolol is a beta-adrenergic blocking agent, commonly referred to as a beta-blocker. It is primarily used to treat various cardiovascular conditions. It is typically taken in the morning. The reported plasma half-life is about 6 hours, which shapes dosing frequency.
Source: DoseRoutine — https://doseroutine.com/library/atenolol
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Atenolol — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/atenolol
What compounds are similar to Atenolol?
Others in the medication category or studied for the same goals.